Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion

Title
Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion
Authors
Keywords
cancer; c-Met; small molecule inhibitor; microenvironment; HGF
Journal
Oncotarget
Volume 10, Issue 2, Pages -
Publisher
Impact Journals, LLC
Online
2019-01-05
DOI
10.18632/oncotarget.26546

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started